Toyonaka, Japan

Hiroki Kusano

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Toyonaka, JP (2015)
  • Osaka, JP (2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hiroki Kusano

Introduction

Hiroki Kusano, a prominent inventor based in Toyonaka, Japan, has made significant strides in the field of antimicrobial research. With a total of three patents to his name, Kusano is dedicated to developing innovative compounds that target a range of bacterial infections, particularly those caused by multi-drug resistant organisms.

Latest Patents

Among Kusano's latest patents are two notable inventions focusing on 2-substituted cephem compounds. The first patent addresses the creation of these compounds, which exhibit a wide antimicrobial spectrum, particularly showing potent activity against beta-lactamase producing Gram-negative bacteria. This is crucial in today’s medical landscape, where antibiotic resistance is a growing concern.

The second patent details a cephem compound featuring a catechol group, designed to treat bacterial infectious diseases. This invention provides various forms of the compound, including esters, protected forms, and pharmaceutically acceptable salts. The effectiveness of these cephem compounds extends to multi-drug resistant microorganisms, particularly those producing Class B type metallo-beta-lactamases and extended-spectrum beta-lactamase (ESBL) bacteria. Importantly, these compounds do not exhibit cross-resistance with existing cephem or carbapenem drugs, making them vital alternatives in antibiotic therapy.

Career Highlights

Hiroki Kusano has contributed significantly to the pharmaceutical industry, holding impactful positions at leading companies. He has worked at Shionogi & Company Limited, as well as Glaxo Group Limited, where his research has focused on antimicrobial agents and their applications in treating infectious diseases.

Collaborations

Throughout his career, Kusano has collaborated with notable colleagues such as Kenji Yamawaki and Toshiaki Aoki. This teamwork has been instrumental in advancing his research and enhancing the effectiveness of his inventions.

Conclusion

Hiroki Kusano's contributions to the field of antimicrobial compounds reflect his commitment to innovation and excellence in pharmaceutical research. His patents not only address urgent medical needs but also demonstrate the potential for developing effective treatments against resistant bacteria. As the landscape of infectious diseases continues to evolve, inventors like Kusano play a crucial role in pioneering solutions that benefit public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…